Point-of-care diagnostics for the real world
The SAMBA (Simple AMplification Based Assay) system is an innovative nucleic acid-based rapid test particularly suitable for HIV diagnostics. A key feature is its ability to provide a “test and treat” facility at the point-of-care and, critically, to do so in resource-limited areas where reliable diagnosis and monitoring would otherwise be unavailable.
Early infant diagnosis
Acute infection diagnosis
Viral load for therapy monitoring
The SAMBA platform offers qualitative or semi-quantitative detection of analytes such as HIV RNA in plasma samples for use as an aid in the diagnosis and monitoring of HIV infection especially in babies and in anti-retroviral therapy monitoring.
SAMBA is delivered through two discrete assay instruments: SAMBA I and SAMBA II. Both platforms use the same chemistry but are designed to meet different operational needs.
Assays in development for the SAMBA platform include tests for hepatitis B and C, influenza A and B, as well as a duplex test for chlamydia and gonorrhea.
Whole Blood Qualitative test for Early Infant and Acute Infection Diagnosis
Plasma Semi-Quantitative test:
Concordance: 96-99% compared to centralised testing